Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1999 1
2003 1
2005 3
2006 1
2007 1
2009 1
2010 1
2015 1
2016 1
2017 1
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Toxicity of the topoisomerase II inhibitors.
Seiter K. Seiter K. Expert Opin Drug Saf. 2005 Mar;4(2):219-34. doi: 10.1517/14740338.4.2.219. Expert Opin Drug Saf. 2005. PMID: 15794715 Review.
Novel synthetic pyridyl analogues of CDDO-Imidazolide are useful new tools in cancer prevention.
Cao M, Onyango EO, Williams CR, Royce DB, Gribble GW, Sporn MB, Liby KT. Cao M, et al. Pharmacol Res. 2015 Oct;100:135-47. doi: 10.1016/j.phrs.2015.07.024. Epub 2015 Jul 31. Pharmacol Res. 2015. PMID: 26238177
The new compounds suppressed inducible nitric oxide synthase (iNOS) expression in RAW264.7 macrophage-like cells and significantly elevated heme oxygenase-1 (HO-1) and quinone reductase (NQO1) mRNA and protein levels in various mouse tissues in vivo. ...
The new compounds suppressed inducible nitric oxide synthase (iNOS) expression in RAW264.7 macrophage-like cells and significantly elevated …
Absence of an interaction between artesunate and atovaquone--proguanil.
van Vugt M, Edstein MD, Proux S, Lay K, Ooh M, Looareesuwan S, White NJ, Nosten F. van Vugt M, et al. Eur J Clin Pharmacol. 1999 Aug;55(6):469-74. doi: 10.1007/s002280050658. Eur J Clin Pharmacol. 1999. PMID: 10492061 Clinical Trial.
To investigate whether artesunate affects the pharmacokinetics of atovaquone plus proguanil, and to provide preliminary information regarding the tolerability of the triple drug combination (artesunate plus atovaquone plus proguanil), a cross over study was conducted in adult vol …
To investigate whether artesunate affects the pharmacokinetics of atovaquone plus proguanil, and to provide preliminary information regardin …
Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice.
Jonscher KR, Stewart MS, Alfonso-Garcia A, DeFelice BC, Wang XX, Luo Y, Levi M, Heerwagen MJ, Janssen RC, de la Houssaye BA, Wiitala E, Florey G, Jonscher RL, Potma EO, Fiehn O, Friedman JE. Jonscher KR, et al. FASEB J. 2017 Apr;31(4):1434-1448. doi: 10.1096/fj.201600906R. Epub 2016 Dec 22. FASEB J. 2017. PMID: 28007783 Free PMC article.
Early exposure to maternal obesity or Western-style diet (WD) increases steatosis and oxidative stress in fetal liver and is associated with lifetime disease risk in the offspring. Pyrroloquinoline quinone (PQQ) is a natural antioxidant found in soil, enriched in human bre …
Early exposure to maternal obesity or Western-style diet (WD) increases steatosis and oxidative stress in fetal liver and is associated with …
Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
McGready R, Keo NK, Villegas L, White NJ, Looareesuwan S, Nosten F. McGready R, et al. Trans R Soc Trop Med Hyg. 2003 Sep-Oct;97(5):592-4. doi: 10.1016/s0035-9203(03)80040-8. Trans R Soc Trop Med Hyg. 2003. PMID: 15307434
Between April 1999 and October 2001, we treated and prospectively followed 27 Karen pregnant women with multiple recrudescent P. falciparum infections who were resistant to all other antimalarials with a triple combination of artesunate-atovaquone-proguanil. ...
Between April 1999 and October 2001, we treated and prospectively followed 27 Karen pregnant women with multiple recrudescent P. falc …
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
McGready R, Ashley EA, Moo E, Cho T, Barends M, Hutagalung R, Looareesuwan S, White NJ, Nosten F. McGready R, et al. J Infect Dis. 2005 Sep 1;192(5):846-53. doi: 10.1086/432551. Epub 2005 Jul 27. J Infect Dis. 2005. PMID: 16088834 Clinical Trial.
BACKGROUND: There is no safe, practical, and effective treatment for pregnant women infected with multidrug-resistant Plasmodium falciparum. METHODS: We recruited pregnant Karen women in the second or third trimesters of pregnancy who had uncomplicated falciparum malaria f …
BACKGROUND: There is no safe, practical, and effective treatment for pregnant women infected with multidrug-resistant Plasmodium falciparum. …
15 results